A 'mild' COVID-19 case just means you don't end up in the hospital, epidemiologists caution

A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
There was good news and bad news about COVID-19 and its Omicron variant on Tuesday.
U.S. health officials said the new variant is spreading fast and will soon become the dominant coronavirus strain in the U.S., demoting Delta, but Pfizer announced that its new antiviral drug Paxlovid has proved extremely effective at keeping high-risk COVID-19 patients alive and out of the hospital, and appears to work against the Omicron variant. A South African study found that two doses of Pfizer's vaccine was only 33 percent effective against Omicron infection and 70 percent effective at preventing hospitalization and death, but also that the illness from this new variant appears more mild than with previous strains.
Even if Omicron proves to be more mild, "'mild' doesn't mean 'no big deal,'" Joanne Kenen cautions in Politico's Nightly newsletter. "Mild Covid-19 can still cause a whole lot of illness, a whole lot of economic disruption, a whole lot of strain on health care systems around the world." For one thing, if the new variant were 75 percent less deadly than previous strains but infected four times as many people, "the same number of lives would be lost," she notes. And for people who recover, nobody knows about Omicron and lingering long-COVID symptoms.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Also, "'mild' to an epidemiologist doesn't mean the same thing that 'mild' indicates to you and me," Kenen adds. "Mild to us means not feeling so bad. Mild to the public health professional just means you aren't in the hospital."
A virus "can knock you off your feet and debilitate you for a few days and we'd still call it mild," said Marcus Plescia, chief medical officer at the American Society of State and Territorial Health Officials. "Mild" covers everything from the sniffles to being bedridden with fever and aches, adds Megan Ranney, an emergency physician at Brown University. "Even if I don't get super-sick, thanks to the vaccines," she told Nightly, "I can't afford to take 10 days off of work." Read more at Politico.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Peter Weber is a senior editor at TheWeek.com, and has handled the editorial night shift since the website launched in 2008. A graduate of Northwestern University, Peter has worked at Facts on File and The New York Times Magazine. He speaks Spanish and Italian and plays bass and rhythm cello in an Austin rock band. Follow him on Twitter.
-
All about Zealandia, the Earth’s potential 8th continent
The Explainer The secret continent went undiscovered for over 300 years
By Devika Rao Published
-
A reckoning over looted art
The Explainer Thousands of artifacts in U.S. and European collections were stolen from their countries of origin. Should they be sent back?
By The Week Staff Published
-
A surge in surge pricing
Feature And more of the week's best financial insight
By The Week Staff Published
-
How do we calculate mass deaths?
The Explainer Recent revisions to 9/11, Libyan flood and Covid-19 death tolls raise questions over estimates
By Harriet Marsden, The Week UK Published
-
You can now get a new Covid booster shot. Should you?
Unless you are old or otherwise at high risk, it isn't a 'slam dunk'
By Peter Weber Published
-
FDA to re-evaluate effectiveness of common nasal congestion ingredient
Speed Read
By Justin Klawans Published
-
A flesh-eating bacteria is growing in numbers due to climate change
Speed Read
By Devika Rao Published
-
CDC recommends new RSV vaccine for infants under 8 months
Speed Read
By Devika Rao Published
-
U.S. health agency advises easing federal marijuana restrictions
Speed Read
By Peter Weber Published
-
Medicare drug price negotiations start with 1st 10 drugs, pharmaceutical industry lawsuits
Speed Read
By Peter Weber Published
-
Is it time to mask up again?
Today's Big Question A rise in Covid-19 cases brings back the possibility of mask mandates
By Joel Mathis Published